"The Dialysis Access Institute (DAI) was established at Regional Medical Center in March 2011 to serve patients with end-stage renal disease for whom access to the bloodstream needs to be established or has been compromised. The DAI team performs more than 3,700 procedures/operations each year, and physicians from throughout the world visit RMC to be trained in these procedures. The DAI is accredited by the American Society of Diagnostic & Interventional Nephrology as a hemodialysis vascular access training center. This is the only fulltime, dedicated access center in existence."

During the past decade, Vascular Access Solutions conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vascular Access Solutions" are "Arterial Occlusive Diseases" (2 trials), "Peripheral Arterial Disease" (2 trials), "Peripheral Vascular Diseases" (2 trials), "Deep Vein Thrombosis" (1 trials) and "Femoral Artery Occlusion" (1 trials). Many other conditions were trialed in "Vascular Access Solutions" in a lesser frequency.

Most popular intervention types in "Vascular Access Solutions" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Lutonix® 035 Drug Coated Balloon PTA Catheter" (1 trials), "PTA (Lutonix® 035 DCB Catheter)" (1 trials), "PTA (UltraScore Focused Force PTA Balloon)" (1 trials) and "vena cava filter implantation (LUMIFI with Crux VCF System)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vascular Access Solutions" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vascular Access Solutions". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vascular Access Solutions, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vascular Access Solutions, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".